Exploiting Iron Metabolism as a Therapeutic Vulnerability in Glioblastoma

被引：3
|
作者：
Nabavizadeh, Ali [1 ,3 ]
Bagley, Stephen J. [2 ]
机构：
[1] Univ Penn, Hosp Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[3] Hosp Univ Penn, Dept Radiol, Silverstein Bldg 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
CLINICAL CANCER RESEARCH | 2024年 / 30卷 / 02期
关键词：
D O I：
10.1158/1078-0432.CCR-23-3027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this CCR Translations, we discuss pharmacologic ascorbate as a novel therapeutic for glioblastoma (GBM). Aberrant iron metabolism in GBM can be assessed noninvasively by MRI and exploited to potentially improve the efficacy of chemoradiotherapy. We contextualize the study's results and discuss the next steps to further develop this paradigm.
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] Dysregulated cholesterol synthesis is a therapeutic vulnerability in glioblastoma
    Kambach, Diane M.
    Halim, Alan S.
    Cauer, A. Gesine
    Sun, Qian
    Tristan, Carlos A.
    Celiku, Orieta
    Kesarwala, Aparna H.
    Shankavaram, Uma
    Batchelor, Eric
    Stommel, Jayne M.
    CANCER RESEARCH, 2017, 77
  • [2] Glioblastoma Metabolism: Insights and Therapeutic Strategies
    Bernhard, Chloe
    Reita, Damien
    Martin, Sophie
    Entz-Werle, Natacha
    Dontenwill, Monique
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [3] Dysregulated mevalonate and cholesterol synthesis is a therapeutic vulnerability in glioblastoma
    Kambach, Diane M.
    Halim, Alan S.
    Cauer, A. Gesine
    Sun, Qian
    Tristan, Carlos A.
    Kesarwala, Aparna H.
    Shankavaram, Uma
    Batchelor, Eric
    Stommel, Jayne M.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] Exploiting altered methionine metabolism to overcome treatment resistance in glioblastoma
    Korimerla, Navyateja
    Romans, Kari-Wilder
    Kalev, Peter
    Kothari, Ayesha
    Qi, Nathan
    Evans, Charles
    Kachman, Maureen
    Hyer, Marc L.
    Marjon, Katya
    Wahl, Daniel R.
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Exploiting Enhanced Lipid Metabolism in Glioblastoma through Diet Modification
    Kant, S.
    Zhao, Y.
    Kesarwani, P.
    Chinnaiyan, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E113 - E114
  • [6] Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
    Ahmad, Fahim
    Sun, Qian
    Patel, Deven
    Stommel, Jayne M.
    CANCERS, 2019, 11 (02):
  • [7] Lipid metabolism: the potential therapeutic targets in glioblastoma
    Lu Lu
    Yan Zhang
    Yuzhong Yang
    Meihua Jin
    Aiyu Ma
    Xu Wang
    Qiuyu Zhao
    Xuemei Zhang
    Jinhua Zheng
    Xiang Zheng
    Cell Death Discovery, 11 (1)
  • [8] GALLIUM MALTOLATE INTERFERES WITH IRON METABOLISM IN GLIOBLASTOMA
    Al-Gizawiy, Mona M.
    Wereley, Janine P.
    Schmainda, Kathleen M.
    Chitambar, Christopher R.
    NEURO-ONCOLOGY, 2016, 18 : 63 - 64
  • [9] Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile
    Audrey Burban
    Cloe Tessier
    Mathieu Larroquette
    Joris Guyon
    Cloe Lubiato
    Mathis Pinglaut
    Maxime Toujas
    Johanna Galvis
    Benjamin Dartigues
    Emmanuelle Georget
    H Artee Luchman
    Samuel Weiss
    David Cappellen
    Nathalie Nicot
    Barbara Klink
    Macha Nikolski
    Lucie Brisson
    Thomas Mathivet
    Andreas Bikfalvi
    Thomas Daubon
    Ahmad Sharanek
    EMBO Molecular Medicine, 2025, 17 (3) : 469 - 503
  • [10] Purine metabolism promotes radioresistance and is a therapeutic target in glioblastoma
    Zhou, Weihua
    Wahl, Daniel R.
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (06)
12345